These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 23683484)
1. Bullous pemphigoid with prominent milium formation. Tsuruta D; Brzezinski P; Koga H; Ohata C; Furumura M; Hashimoto T Acta Dermatovenerol Croat; 2013; 21(1):35-8. PubMed ID: 23683484 [TBL] [Abstract][Full Text] [Related]
2. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin. Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386 [TBL] [Abstract][Full Text] [Related]
3. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia. Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Yang B; Wang C; Chen S; Chen X; Zhou G; Tian H; Yu M; Zhang D; Shi Z; Zhang F Indian J Dermatol Venereol Leprol; 2011; 77(6):677-82. PubMed ID: 22016274 [TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049 [TBL] [Abstract][Full Text] [Related]
7. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis. Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162 [TBL] [Abstract][Full Text] [Related]
8. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid. Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881 [TBL] [Abstract][Full Text] [Related]
10. 'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. Feliciani C; Di Muzio M; Mohammad Pour S; Allegretti T; Amerio P; Toto P; Coscione G; Proietto G; Amerio P J Eur Acad Dermatol Venereol; 1998 May; 10(3):243-7. PubMed ID: 9643329 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734 [TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764 [TBL] [Abstract][Full Text] [Related]
13. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities. Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720 [TBL] [Abstract][Full Text] [Related]
14. Refractory bullous pemphigoid leaving numerous milia during recovery. Uchida S; Oiso N; Koga H; Ishii N; Okahashi K; Matsuda H; Hashimoto T; Kawada A J Dermatol; 2014 Nov; 41(11):1003-5. PubMed ID: 25346302 [TBL] [Abstract][Full Text] [Related]
15. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371 [TBL] [Abstract][Full Text] [Related]
16. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum. Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183 [TBL] [Abstract][Full Text] [Related]
17. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence. Gardner KM; Crawford RI J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980 [TBL] [Abstract][Full Text] [Related]
18. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis. Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory epidermolysis bullosa acquisita: case report. Fernandes MD; Chiminazzo MD; Tebcherani AJ; Aoki V; Sanchez AP An Bras Dermatol; 2009; 84(2):181-4. PubMed ID: 19503987 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa. Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]